Detection of perineural tumor invasion of the head and neck: Clinical use of thallium-201 SPECT/CT image fusion

Tadaki Nakahara, Takayuki Suzuki, Etsuo Kunieda, Suketaka Momoshima, Naoyuki Shigematsu, Atsushi Kubo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A patient with adenoid cystic carcinoma of the skull base was treated with radiotherapy because of perineural tumor invasion (PTI). Treatment evaluation using magnetic resonance (MR) imaging showed disease progression of PTI outside the irradiated area, whereas it was difficult to evaluate the therapeutic effect of radiotherapy because the irradiated lesions still had contrast enhancement. Thallium-201 SPECT/CT image fusion was performed to evaluate tumor extent and viability after therapy. During the follow-up period, disease progression was noted in the areas of abnormal uptake on the thallium-201 SPECT/CT fusion images, but the lesions with no uptake remained unchanged on follow-up MR imaging. Thallium-201 SPECT/CT image fusion can be used for precise localization of viable PTI in head and neck cancer patients who had been previously treated.

Original languageEnglish
Pages (from-to)567-570
Number of pages4
JournalClinical Nuclear Medicine
Volume33
Issue number8
DOIs
Publication statusPublished - 2008 Aug

Fingerprint

Thallium
Neck
Head
Disease Progression
Neoplasms
Radiotherapy
Magnetic Resonance Imaging
Adenoid Cystic Carcinoma
Skull Base
Therapeutic Uses
Head and Neck Neoplasms
Single Photon Emission Computed Tomography Computed Tomography
Therapeutics

Keywords

  • Adenoid cystic carcinoma
  • Perineural tumor invasion
  • Radiotherapy
  • SPECT/CT
  • Thallium-201

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Detection of perineural tumor invasion of the head and neck : Clinical use of thallium-201 SPECT/CT image fusion. / Nakahara, Tadaki; Suzuki, Takayuki; Kunieda, Etsuo; Momoshima, Suketaka; Shigematsu, Naoyuki; Kubo, Atsushi.

In: Clinical Nuclear Medicine, Vol. 33, No. 8, 08.2008, p. 567-570.

Research output: Contribution to journalArticle

@article{2b6f53038ab14e31a417f780e483ed13,
title = "Detection of perineural tumor invasion of the head and neck: Clinical use of thallium-201 SPECT/CT image fusion",
abstract = "A patient with adenoid cystic carcinoma of the skull base was treated with radiotherapy because of perineural tumor invasion (PTI). Treatment evaluation using magnetic resonance (MR) imaging showed disease progression of PTI outside the irradiated area, whereas it was difficult to evaluate the therapeutic effect of radiotherapy because the irradiated lesions still had contrast enhancement. Thallium-201 SPECT/CT image fusion was performed to evaluate tumor extent and viability after therapy. During the follow-up period, disease progression was noted in the areas of abnormal uptake on the thallium-201 SPECT/CT fusion images, but the lesions with no uptake remained unchanged on follow-up MR imaging. Thallium-201 SPECT/CT image fusion can be used for precise localization of viable PTI in head and neck cancer patients who had been previously treated.",
keywords = "Adenoid cystic carcinoma, Perineural tumor invasion, Radiotherapy, SPECT/CT, Thallium-201",
author = "Tadaki Nakahara and Takayuki Suzuki and Etsuo Kunieda and Suketaka Momoshima and Naoyuki Shigematsu and Atsushi Kubo",
year = "2008",
month = "8",
doi = "10.1097/RLU.0b013e31817dea6b",
language = "English",
volume = "33",
pages = "567--570",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Detection of perineural tumor invasion of the head and neck

T2 - Clinical use of thallium-201 SPECT/CT image fusion

AU - Nakahara, Tadaki

AU - Suzuki, Takayuki

AU - Kunieda, Etsuo

AU - Momoshima, Suketaka

AU - Shigematsu, Naoyuki

AU - Kubo, Atsushi

PY - 2008/8

Y1 - 2008/8

N2 - A patient with adenoid cystic carcinoma of the skull base was treated with radiotherapy because of perineural tumor invasion (PTI). Treatment evaluation using magnetic resonance (MR) imaging showed disease progression of PTI outside the irradiated area, whereas it was difficult to evaluate the therapeutic effect of radiotherapy because the irradiated lesions still had contrast enhancement. Thallium-201 SPECT/CT image fusion was performed to evaluate tumor extent and viability after therapy. During the follow-up period, disease progression was noted in the areas of abnormal uptake on the thallium-201 SPECT/CT fusion images, but the lesions with no uptake remained unchanged on follow-up MR imaging. Thallium-201 SPECT/CT image fusion can be used for precise localization of viable PTI in head and neck cancer patients who had been previously treated.

AB - A patient with adenoid cystic carcinoma of the skull base was treated with radiotherapy because of perineural tumor invasion (PTI). Treatment evaluation using magnetic resonance (MR) imaging showed disease progression of PTI outside the irradiated area, whereas it was difficult to evaluate the therapeutic effect of radiotherapy because the irradiated lesions still had contrast enhancement. Thallium-201 SPECT/CT image fusion was performed to evaluate tumor extent and viability after therapy. During the follow-up period, disease progression was noted in the areas of abnormal uptake on the thallium-201 SPECT/CT fusion images, but the lesions with no uptake remained unchanged on follow-up MR imaging. Thallium-201 SPECT/CT image fusion can be used for precise localization of viable PTI in head and neck cancer patients who had been previously treated.

KW - Adenoid cystic carcinoma

KW - Perineural tumor invasion

KW - Radiotherapy

KW - SPECT/CT

KW - Thallium-201

UR - http://www.scopus.com/inward/record.url?scp=51249086111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51249086111&partnerID=8YFLogxK

U2 - 10.1097/RLU.0b013e31817dea6b

DO - 10.1097/RLU.0b013e31817dea6b

M3 - Article

C2 - 18645382

AN - SCOPUS:51249086111

VL - 33

SP - 567

EP - 570

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 8

ER -